Oasmia Pharmaceutical AB ADR (USD)
OASMY
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.33 | 1.33
52-Wk Range0.94 | 3.70
Last Close1.53
Mkt Cap (m)156.05
Dividend yield-
ISINUS67421W1099
Volume500
Exchange VenuePINX

Company Profile

Oasmia Pharmaceutical AB is a pharmaceutical company. It develops a new generation of drugs within human and veterinary oncology. It has two approved products: Paclical and Paccal Vet-CA1.

Key Information
Price/Earning-
Price/Book4.29
Price/Sales750.91
P/CF-
Rev Growth (3 year avg)-32.27
EPS Growth (3 year avg)-
Operating Margin % -7642.93
Net Margin %-10196.26
Return on Equity-54.70
Debt/Equity0.35

Legal Documents

Prospectus
en 27/11/2019
Annual Report
en 30/04/2019

Financials

Income Statement
USD201320142015201620172018
Revenue (m)263
Operating Income (m)-68-98-108-133-141-104
Net Income (m)-72-105-117-142-160-118
Basic EPS-1.97-2.38-2.40-2.61-2.66-1.40
Avg. Diluted Shares Outstanding (m)374449546084
Balance Sheet
USD201320142015201620172018
Current Assets (m)705487735081
Non Current Assets (m)375414428443471488
Total Assets (m)445468515516522568
Current Liabilities (m)125186139190221223
Total Liabilities (m)------
Total Equity (m)319282376326300345
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-70-87-108-128-133-124
Capital Expenditure (m)-64-36-21-20-8-21
Figures are quoted in USD unless stated otherwise
-0.20 (-13.07%)
$
1.33
Last Price